Skip to main content
Clinical Trials/NCT02886247
NCT02886247RecruitingNot Applicable

National Familial Pancreas Tumor Registry

Johns Hopkins University1 site in 1 country12,000 target enrollmentStarted: June 1, 1994Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
12,000
Locations
1
Primary Endpoint
pancreatic cancer

Study Overview

Brief Summary

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer to cluster in some families. Up to 10% of pancreatic cancer patients have another close relative who has also developed pancreatic cancer. This clustering of pancreatic cancers in families has yet to be explained; however, the investigators continue to identify new familial pancreatic cancer genes that explain this clustering in subsets of families. For example, in 2009 and 2012 the investigators discovered that mutations in the PALB2 and ATM genes jointly account up to 5% of the clustering of pancreatic cancer in families.

Study Design

Study Type
Observational
Observational Model
Family Based
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •personal or family history of pancreas tumors

Exclusion Criteria

  • Not provided

Arms & Interventions

participants

individuals with a personal or family history of pancreas tumors

Outcomes

Primary Outcomes

pancreatic cancer

Time Frame: 35 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Johns Hopkins University
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials